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to wild-type mice. In HBSMC incubated with IL-13 or IL-4, the 
expression of ryanodine receptors, inositol-3-phosphate re-
ceptors and sarcoplasmic/endoplasmic reticulum Ca 2+ 
ATPases 2 was increased compared to HBSMC without incu-
bation with interleukins. The enlarged acetylcholine-in-
duced Ca 2+ transients could be reversed by blocking inosi-
tol-3-phosphate receptors.  Conclusions: We conclude that 
in the murine asthma model the SR Ca 2+ buffer capacity is 
increased, while in the human asthma model the expression 
of SR Ca 2+ channels is altered. The investigation of the Ca 2+ 
homeostasis of ASMC has the potential to provide new ther-
apeutical options in asthma. 
 
Copyright © 2008 S. Karger AG, Basel 
 Introduction 
 In the second half of the 20th century, asthma has be-
come a worldwide epidemic and its prevalence is still in-
creasing  [1] . For example, the prevalence of asthma among 
US children increased from 3.6% in 1980 to 5.8% in 2003, 
and asthma is the third leading cause of hospitalization 
among persons under 18 years of age in the US  [2] . Al-
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 Abstract 
 Background: Asthma is characterized by airway remodel-
ing, altered mucus production and airway smooth muscle 
cell (ASMC) contraction causing extensive airway narrowing. 
In particular, alterations of ASMC contractility seem to be of 
crucial importance. The elevation of the cytoplasmic Ca 2+ 
concentration is a key event leading to ASMC contraction 
and changes in the agonist-induced Ca 2+ increase in ASMC 
have been reported in asthma.  Objective: The aim of this 
study was to investigate mechanisms underlying these 
changes.  Methods: Murine tracheal smooth muscle cells 
(MTSMC) from T-bet KO mice and human bronchial smooth 
muscle cells (HBSMC) incubated with IL-13 and IL-4 served as 
asthma models. Acetylcholine-induced changes in the cyto-
plasmic Ca 2+ concentration were recorded using fluores-
cence microscopy and the expression of Ca 2+ homeostasis 
regulating proteins was investigated with Western blot anal-
ysis.  Results: Acetylcholine-induced Ca 2+ transients were el-
evated in both asthma models. This correlated with an in-
creased Ca 2+ content of the sarcoplasmic reticulum (SR). In 
MTSMC from T-bet KO mice, the expression of the SR Ca 2+ 
buffers calreticulin and calsequestrin was higher compared 
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though inhaled corticosteroids have become a standard 
therapy assuring symptom control in many cases, they 
represent a broad-spectrum anti-inflammatory ap-
proach. Specific therapies targeting pathological alter-
ations particularly found in asthma are still to be devel-
oped and a deeper understanding of the pathogenesis of 
asthma is a prerequisite for such specific therapies.
 Asthma is characterized by airway remodeling, altered 
mucus production and airway smooth muscle cell (ASMC) 
contraction causing extensive airway narrowing. Altera-
tions of ASMC seem to be of utmost importance in asth-
ma, as its ablation by bronchoscopic ther moplasty led to 
marked improvement of asthma  [3] . However, the ques-
tion arises if similar effects may be achievable using phar-
macological and thereby less invasive interventions. Based 
on this, the cellular mechanisms leading to excessive 
ASMC contraction are of particular interest.
 The elevation of the cytoplasmic Ca 2+ concentration, 
[Ca 2+ ] c , is a key event leading to ASMC contraction  [4–7] . 
Consequently, agonist-induced Ca 2+ signaling has been 
regarded as a possible target in the pathophysiology of 
asthma  [8–11] . In fact, in hyperresponsive inbred rats, en-
hanced Ca 2+ mobilization was correlated with bronchial 
hyperresponsiveness  [12–14] . Several studies have shown 
that Ca 2+ responses can be modulated by a multitude of 
stimuli, including the cytokines IL-1   [15, 16] , TNF-  
 [17–19] , IL-4 and IL-13  [20–24] . In addition, CD38/cyclic 
ADP-ribose-mediated Ca 2+ signaling has been found to 
contribute to ASMC hyperresponsiveness  [25–28] .
 T-bet is a T H 1-specific transcription factor, which has 
the ability to direct T H 2 into T H 1 cells  [29] . Naïve mice 
that have been target deleted of the T-bet gene (T-bet KO 
mice) spontaneously develop airway remodeling very 
similar to that seen in asthma and demonstrate multiple 
functional and inflammatory features characteristic of 
this disease  [30] . Finotto et al.  [31] showed that these al-
terations are mediated by IL-13. Recently, we used lung 
slices from T-bet KO mice as an asthma model and found 
both the acetylcholine (ACH)-induced airway contrac-
tion and the ACH-induced Ca 2+ increase to be elevated 
 [32] . The question arises as to what mechanisms may me-
diate the altered Ca 2+ homeostasis in asthma. The explo-
ration of that question was the aim of the present study.
 In a former investigation, we used lung slices from T-
bet KO mice, but we chose to use cultured ASMC from 
these mice in the present study. The reason for this was 
the fact that we aimed at performing Western blot analy-
sis to investigate the protein expression in ASMC. In lung 
slices, this analysis would have been impaired by the 
abundant presence of non-smooth muscle cells like fibro-
blasts, epithelial and alveolar cells. In a different study, 
we recently investigated the effects of IL-4 and IL-13 on 
the ACH-induced Ca 2+ signaling and receptor expression 
using primary cultured human bronchial smooth muscle 
cells (HBSMC). After incubation with 50 ng/ml IL-4 or 
IL-13 we found the ACH-induced Ca 2+ transient to be el-
evated  [22] . Therefore, HBSMC served as an additional 
asthma model in this study.
 In the present communication, using 2 different asth-
ma models, we showed that ACH-induced Ca 2+ tran-
sients in ASMC were increased. This correlated in both 
models with increased Ca 2+ contents of the sarcoplasmic 
reticulum (SR). We further showed that in ASMC from 
T-bet KO mice the expression of the SR Ca 2+ buffers cal-
reticulin and calsequestrin was elevated. In contrast, in 
human ASMC incubated with IL-13 or IL-4, the expres-
sion of ryanodine receptors (RyR), inositol-3-phosphate 
receptors (IP 3 R) and sarcoplasmic/endoplasmic reticu-
lum Ca 2+ ATPases 2 (SERCA 2) was increased.
 Material and Methods 
 Cell culture reagents were obtained from Life Technologies 
(Eggenstein, Germany). Other reagents were bought from Sigma-
Aldrich (Deisenhofen, Germany) unless stated otherwise. Balb/C 
mice were purchased from Harlan-Winkelmann (Borchen, Ger-
many) and T-bet KO mice on a Balb/C background from Charles 
River (Needham, Mass., USA). All procedures were approved by 
the Ethics Committee of the Ludwig Maximilian University Mu-
nich.
 To grow murine tracheal smooth muscle cells (MTSMC), mice 
aged 42–77 days were sacrificed by intraperitoneal injection of 
phenobarbital. The trachea was excised, the connective tissue and 
the epithelium removed, and the trachea was placed in 3 mg/ml 
(720 U/ml) collagenase for 1 h. The harvested cells were washed 
and seeded on rat collagen-covered tissue plates to prevent growth 
of fibroblasts. MTSMC were identified by anti-  -actin staining 
and contractile responses to ACH. Primary cultured HBSMC 
were purchased from Cambrex Bio Science (Charles City, Iowa, 
USA), grown as monolayer and incubated for 24 h with recombi-
nant human IL-4 or IL-13 (R&D Systems, Minneapolis, Minn., 
USA). In a previous study, dose-response curves for both interleu-
kins were performed with 50 ng/ml, providing maximum effects 
in terms of contractile responses to ACH and morphological 
changes  [22] . Therefore, this concentration was used in the pres-
ent study. HBSMC without incubation with interleukins served 
as controls.
 To quantify the ACH-induced Ca 2+ increase, MTSMC (1 m M 
ACH) and HBSMC (1   M ACH) were loaded for 30 min at 37 ° C 
with the calcium indicator dye Oregon Green (10   M ; Molecular 
Probes, Eugene, Oreg., USA) in supplemented Hanks balanced 
salt solution containing 0.2% Pluronic (Pluronic F-127; Calbio-
chem, La Jolla, Calif., USA). After loading, the cells were incu-
bated for at least 30 min in supplemented Hanks balanced salt 
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solution to allow for complete dye de-esterification and examined 
with a fluorescence microscope (Axiovert 200  M ; Carl Zeiss, Jena, 
Germany). Images were recorded in time lapse (0.5 or 1 frame/s) 
using a digital CCD camera (AxioCam MRm; Carl Zeiss Vision, 
Munich, Germany). For each image, regions of interest were de-
fined in single cells, and the average fluorescence intensity of each 
region of interest was measured. Final fluorescence values were 
expressed as a fluorescence ratio (F/F 0 ) normalized to the initial 
fluorescence (F 0 ). Each analysis was performed using custom-
written macros in the image analysis software Scion.
 To perform Western blot analysis with MTSMC, the cells were 
washed twice with ice-cold phosphate-buffered saline (10 m M , pH 
7.4) and trypsinized or scraped in 0.02% EDTA solution for in-
tracellular or transmembrane proteins, respectively. The cell 
 suspensions were treated according to user protocols using the 
Mammalian Protein Preparation Kit (Qiagen GmbH, Hilden, 
Germany) for intracellular proteins and Native Membrane Pro-
tein Extraction Kit (Merck Biosciences, Darmstadt, Germany) for 
transmembrane proteins. The extracts were collected, aliquoted 
and then stored at –20 ° C until use with Western blot analysis. The 
extracts were treated with Laemmli sample buffer (at a final con-
centration of 32.5 m M Tris, 2.5%   -mercaptoethanol, 1% SDS and 
12.5% glycerol) at 85 ° C for 10 min and separated by SDS-PAGE 
on 4–12% Bis-Tris (for calreticulin, calsequestrin and SERCA 2) 
or 3–8% Tris-acetate mini gels (for IP 3 R and RyR) depending on 
the size of the target protein. Staining was performed using spe-
cific antibodies [rabbit anti-calreticulin, dilution 1: 5,000; rabbit 
anti-calsequestrin, dilution 1: 5,000; goat anti-SERCA2 (Santa 
Cruz Biotechnology), dilution 1: 2,000; goat anti-RyR (Santa Cruz 
Biotechnology), dilution 1: 1,000; rabbit anti-IP 3 R (Santa Cruz 
Biotechnology), dilution 1: 1,500] and secondary antibodies 
[horseradish peroxidase-linked goat anti-rabbit-IgG or donkey 
anti-goat-IgG (Santa Cruz Biotechnology), dilution 1: 10,000]. 
The protein concentrations of the extracts were determined with 
the Non-Interfering Protein Assay Kit according to the manufac-
turer’s protocol (Merck Biosciences).   -Actin served as a loading 
control.
 To perform Western blot analysis with HBSMC, the cells were 
incubated for 24 h with 50 ng/ml IL-4 and IL-13. Protein expres-
sion was determined by immunoblotting with protein extracts 
prepared with the Compartmental Protein Extraction Kit (Chem-
icon International, Hampshire, UK) according to the manufac-
turer’s instructions. Protein concentrations of the extracts were 
quantified using the Bradford protein assay kit (Bio-Rad, Munich, 
Germany). Proteins were separated by SDS-PAGE on a 6% sepa-
rating and 4% stacking gel (for SERCA 2), a 4% separating and 3% 
stacking gel (for IP 3 R and RyR) and a 10% separating and 4% 
stacking gel (for calreticulin and calsequestrin), and transferred 
to nitrocellulose membranes (Hybond ECL Membrane; Amer-
sham Biosciences, Little Chalfont, UK). After blocking for 2 h in 
a 5% solution of nonfat dried milk/TBS with 0.05% Tween 20, the 
membranes were incubated overnight at 4 ° C with specific anti-
bodies [mouse anti-SERCA 2-antibody (2A7-A1; Abcam Inc., 
Cambridge, Mass., USA); mouse anti-IP 3 R-antibody (Chemicon 
International); mouse anti-RyR-antibody (34C; Abcam Inc.), di-
lution 1: 1,000; rabbit anti-calreticulin-antibody (H-170; Santa 
Cruz Biotechnology), dilution 1: 1,000]. Sheep anti-mouse or don-
key anti-rabbit IgG horseradish peroxidase-linked whole anti-
bodies (Amersham Biosciences; dilution 1: 1,500) were used as 
secondary antibodies.   -Actin served as a loading control.
 For MTSMC and HBSMC, antibody complexes were visual-
ized using Hyperfilm ECL chemiluminescence (Amersham Bio-
sciences) and evaluated using the ImageJ analysis software.
 Statistical analysis was performed using the Sigma Stat soft-
ware (Jandel Scientific, Chicago, Ill., USA). p  ! 0.05 was consid-
ered statistically significant.
 Results 
 MTSMC and HBSMC were loaded with the Ca 2+ indi-
cator Oregon Green and recorded using fluorescence mi-
croscopy. Exposure to ACH (1 m M for MTSMC, 1   M for 
HBSMC) induced a transient increase in [Ca 2+ ] c ( fig. 1 ). 
To assess the effects of an asthmatic phenotype on the 
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 Fig. 1. MTSMC and HBSMC were loaded with the Ca 2+ indicator 
Oregon Green, monitored using fluorescence microscopy and ex-
posed to ACH. ACH (1   M , arrow) induced a transient increase 
in [Ca 2+ ] c as shown by the representative curve of MTSMC ( a ) and 
HBSMC ( b ). 
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Ca 2+ response, 2 asthma models were used. In the murine 
model, MTSMC from T-bet KO mice served as asthmatic 
ASMC, while MTSMC from wild-type mice served as 
control  [30, 32] . In this setting, the ACH-induced Ca 2+ 
transients were significantly higher in MTSMC from T-
bet KO mice (126% of MTSMC from wild-type mice, n = 
151, p  ! 0.001;  fig. 2 a). In the human model, HBSMC were 
incubated for 24 h with 50 ng/ml IL-13 or IL-4. In a pre-
vious study, dose-response curves for both interleukins 
were performed. Because 50 ng/ml provided maximum 
effects in terms of contractile responses to ACH and mor-
phological changes  [22] , this concentration was used in 
the human asthma model in this study. After incubation 
with IL-13 or IL-4, the ACH-induced Ca 2+ transient was 
increased (IL-13: 128% of controls; IL-4: 132% of controls; 
n = 57, p  ! 0.05 versus controls;  fig. 2 b).
 The equilibrium of the Ca 2+ content of the SR is main-
tained by SERCA pumping calcium into the SR, while 
IP 3 R and RyR release calcium out of the SR ( fig. 3 )  [33] . 
Within the SR, calcium is buffered by the Ca 2+ chelators 
calreticulin and calsequestrin. To test the hypothesis that 
an  increased  Ca 2+  content  of  the  SR  may  have   caused  
the increased Ca 2+ transients in the asthmatic models, 
SERCA were inhibited, leading to a net Ca 2+ efflux out of 
the SR. The resulting increase in [Ca 2+ ] c was used as an 
estimate of the Ca 2+ content of the SR. In the murine 
model, SERCA were inhibited using 10   M thapsigargin. 
The following increase in [Ca 2+ ] c was markedly higher in 
MTSMC from T-bet KO mice (255% of MTSMC from 
wild-type mice, n = 5–30, p  ! 0.05;  fig. 4 a). In HBSMC, 
1   M cyclopiazonic acid (CPA) was used to block SERCA. 
The resulting increase in [Ca 2+ ] c was significantly elevat-
ed after incubation of HBSMC with 50 ng/ml IL-13 or 
IL-4 for 24 h, indicating a higher Ca 2+ content of the SR 
in the asthma model (IL-13: 141% of controls; IL-4: 134% 
of controls; n = 21–92, p  ! 0.05 versus controls;  fig. 4 b). 
Thapsigargin and CPA were used because these com-
pounds caused maximal increase in [Ca 2+ ] c in the respec-
tive cell type.
 To further identify the mechanisms responsible for the 
altered Ca 2+ homeostasis in asthmatic ASMC, the expres-
sion of proteins regulating the Ca 2+ content of the SR 
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 Fig. 2.  a To assess the effects of an asthmatic phenotype on the 
ACH-induced Ca 2+ response, MTSMC from T-bet KO and wild-
type mice were compared. The ACH-induced Ca 2+ transients 
were higher in MTSMC from T-bet KO mice (n = 151).  * p  ! 0.001. 
 b HBSMC were incubated with 50 ng/ml IL-13 or IL-4 for 24 h. 
After incubation with the interleukins, HBSMC showed increased 
ACH-induced Ca 2+ transients (n = 57).  * p  ! 0.05 versus con-
trols. 
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 Fig. 3. In ASMC, the equilibrium of the Ca 2+ content of the SR is 
maintained by SERCA pumping calcium into the SR and IP 3 R and 
RyR releasing calcium out of the SR. Within the SR, calcium is 
buffered by calreticulin and calsequestrin. 
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were investigated by Western blot analysis. IP 3 R is an SR 
Ca 2+ release channel that opens upon the binding of IP 3 . 
In MTSMC, we found no difference between the expres-
sion of this receptor in T-bet KO and wild-type mice (T-
bet KO mice 93% of wild-type mice, n = 13;  fig. 5 a). In 
contrast, incubation of HBSMC with IL-13 or IL-4 con-
siderably increased the expression of IP 3 R (IL-13: 241% of 
controls; IL-4: 209% of controls; n = 5, p  ! 0.001 versus 
controls;  fig. 5 b).
 The other receptor releasing calcium from the SR is 
RyR. In MTSMC, the expression of RyR was very weak, 
prohibiting quantitative analysis. However, no apparent 
differences between T-bet KO and wild-type mice could 
be observed (data not shown). In HBSMC, the expression 
of RyR was stronger and incubation with IL-13 or IL-4 
noticeably increased it (IL-13: 335% of controls; IL-4: 
327% of controls; n = 5, p  ! 0.001 versus controls;  fig. 6 ).
 SERCA pump calcium against a concentration gradi-
ent from the cytoplasm into the SR. So far, 3 SERCA iso-
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 Fig. 4. To assess the Ca 2+ content of the SR, SERCA were inhibited 
and the resulting increase in [Ca 2+ ] c was quantified.  a Using 10 
  M thapsigargin to block SERCA in MTSMC, the resulting in-
crease in [Ca 2+ ] c was markedly higher in MTSMC from T-bet KO 
compared to wild-type mice (n = 5–30).  * p  ! 0.05.  b Blocking 
SERCA in HBSMC with 1   M CPA, the resulting increase in 
[Ca 2+ ] c was significantly elevated after incubation with 50 ng/ml 
IL-13 or IL-4 (n = 21–92).  * p  ! 0.05 versus controls. Thapsigargin 
and CPA were used because these compounds were found to cause 
maximal increase in [Ca 2+ ] c in the respective cell type. 
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 Fig. 5. The expression of IP 3 R was investigated using Western blot 
analysis.  a In MTSMC, no difference between cells from T-bet KO 
and wild-type mice could be observed (n = 13).  b In contrast, in-
cubation of HBSMC with IL-13 or IL-4 considerably increased the 
expression of IP 3 R (n = 5).  * p  ! 0.001. 
 Kellner/Tantzscher/Oelmez/Edelmann/
Fischer/Huber/Bergner
Respiration 2008;76:205–215210
forms have been identified, with SERCA 2 being the iso-
form that is predominant in smooth muscle  [33] . Analyz-
ing the expression of SERCA 2, we found no difference 
between MTSMC from T-bet KO and wild-type mice (T-
bet KO mice 102% of wild-type mice, n = 7;  fig. 7 a). In 
contrast, HBSMC incubated with IL-13 or IL-4 showed 
an increased expression of SERCA 2 (IL-13: 157% of con-
trols; IL-4: 169% of controls; n = 6, p  ! 0.01 versus con-
trols;  fig. 7 b).
 In the SR, calcium binds to specific high-capacity, low-
affinity Ca 2+ buffers to ensure high-capacity Ca 2+ storage 
as well as rapid Ca 2+ release  [33] . The most important SR 
Ca 2+ buffer is believed to be calreticulin. Analyzing the 
expression of calreticulin, we found it slightly but signif-
icantly elevated in MTSMC from T-bet KO mice (107% of 
MTSMC from wild-type mice, n = 6, p  ! 0.05;  fig. 8 a). In 
HBSMC, the expression of calreticulin was modestly el-
evated after incubation with IL-13, but not after incuba-
tion with IL-4 (IL-13: 115% of controls; IL-4: 103% of con-
trols; n = 7, p  ! 0.05 versus controls and IL-4;  fig. 8 b).
 Another SR Ca 2+ buffer is calsequestrin. Analyzing its 
expression in MTSMC, it was found to be weak in cells 
from wild-type mice but stronger in cells from T-bet KO 
mice (189% of MTSMC from wild-type mice, n = 5, p  ! 
0.05;  fig. 9 ). In HBSMC, the expression of calsequestrin 
was too weak to allow quantitative analysis. However, no 
influence of incubation with IL-13 or IL-4 could be ob-
served (data not shown).  Table 1 gives an overview of the 
findings on the expression of the Ca 2+ -regulating pro-
teins that were investigated.
 The agonist-induced elevation in [Ca 2+ ] c is a key event 
leading to ASMC contraction, airway narrowing and fi-
 Fig. 6. Investigating the expression of RyR in MTSMC, it was too 
weak to allow quantitative analysis. However, no apparent differ-
ences between T-bet KO and wild-type mice could be observed 
(data not shown). In HBSMC, the expression of RyR was stronger 
and noticeably further increased after incubation with IL-13 or 
IL-4 (n = 5).  * p  ! 0.001 versus controls. 
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 Fig. 7.  a In MTSMC, no differences between the expression of 
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nally dyspnea in patients with asthma. Based on the find-
ings of this study, the question arises whether the altered 
Ca 2+ signaling cascade in asthma can be influenced using 
specific inhibitors. As an example of such an interven-
tion, we used xestospongins in the HBSMC asthma mod-
el. Xestospongins are a family of potent inhibitors of 
IP 3 R, whose expression we found to be increased after 
incubation with interleukins. Xestospongin C is believed 
to be the most potent one, with xestospongin D being less 
effective  [34] . In HBSMC without interleukin incubation, 
preincubation with 10   M xestospongin D for 30 min sig-
nificantly decreased ACH-induced Ca 2+ transients, while 
incubation with 10   M xestospongin C had no effect (xes-
tospongin D: 86% of controls; xestospongin C: 107% of 
controls; n = 33–57, p  ! 0.05;  fig. 10 a). But, interestingly, 
xestospongin C reversed the increase in the ACH-in-
duced Ca 2+ transients after incubation with IL-13 or IL-4 
(IL-13: 128% of controls without and 94% of controls with 
Table 1. Expression of SR Ca2+ homeostasis-regulating proteins
RyR IP3R SERCA Calre-
ticulin
Calse-
questrin
T-bet KO mice
(MTSMC) ] ] ] d d
IL-13/IL-4
(HBSMC) d d d (d) ]
 Fig. 8.  a Analyzing the expression of the SR Ca 2+ buffer calreticu-
lin, it was slightly, but significantly elevated in MTSMC from T-
bet KO compared to wild-type mice (n = 6).  * p  ! 0.05.  b In HB-
SMC, the expression of calreticulin was modestly elevated after 
incubation with IL-13 but not after incubation with IL-4 (n = 7). 
 * p  ! 0.05 versus IL-4 and controls. 
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trin was higher in cells from T-bet KO compared to wild-type 
mice, which showed only weak expression (n = 5).  * p  ! 0.05. In 
HBSMC, the expression of calsequestrin was too weak to allow 
quantitative analysis. However, no influence of incubation with 
IL-13 or IL-4 could be observed (data not shown). 
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xestospongin C; IL-4: 132% of controls without and 84% 
of controls with xestospongin C; p  ! 0.05, n = 20–57; 
 fig. 10 b).
 Discussion 
 Using 2 different asthma models, we have shown that 
ACH-induced Ca 2+ transients in asthmatic ASMC were 
increased. This correlated in both models with increased 
Ca 2+ contents of the SR. We have further shown that in 
ASMC from T-bet KO mice the expression of the SR Ca 2+ 
buffers calreticulin and calsequestrin was elevated. In 
contrast, in human ASMC incubated with IL-13 or IL-4, 
the expression of RyR, IP 3 R and SERCA 2 was increased.
 In this study, we used 2 asthma models: MTSMC from 
T-bet KO mice and HBSMC incubated with interleukins. 
While HBSMC were commercially purchased, MTSMC 
were isolated from the murine trachea and identified by 
anti-  -actin staining and contractile responses to ACH. 
HBSMC were incubated for 24 h with 50 ng/ml IL-13 or 
IL-4. In a previous study, dose-response curves for both 
interleukins were performed. Because 50 ng/ml provided 
maximum effects in terms of contractile responses to 
ACH and morphological changes  [22] , this concentration 
was used in the human asthma model.
 The 2 models were different in 3 aspects. Firstly, the 
cells originated from different species, namely mice and 
humans. Secondly, cells from the trachea on one hand 
and from bronchi on the other hand were used. Thirdly, 
asthma was mimicked using a genetically engineered 
mouse model or by incubation of cells with IL-13 or IL-4. 
In both models, the ACH-induced Ca 2+ transients were 
increased most probably by elevated Ca 2+ contents of the 
SR. Yet, the mechanisms changing the Ca 2+ homeostasis 
of the SR were different in the 2 experimental settings. 
While in MTSMC the SR Ca 2+ buffers were upregulated, 
the expression of Ca 2+ channels and a Ca 2+ pump was in-
creased in HBSMC. Which or how many of the 3 different 
aspects of the 2 models were responsible for the differ-
ences remains speculatively, but needs to be addressed in 
future studies. However, our results remind us of the 
need to be careful when generalizing results obtained in 
a single experimental model.
 Elevation of the [Ca 2+ ] c can be caused by Ca 2+ release 
from the intracellular Ca 2+ stores or by Ca 2+ influx from 
the extracellular space. In a previous study, we could 
show that in ASMC the latter plays a minor role and prob-
ably only serves to compensate for Ca 2+ losses to the ex-
tracellular space  [4] . But, we explicitly do not exclude the 
possibility that Ca 2+ influx may play a role in the changes 
in the Ca 2+ homeostasis seen in asthma. However, in the 
present study, we concentrated on changes in the regula-
tion of the SR Ca 2+ content.
 The increased Ca 2+ transients were correlated with an 
increased Ca 2+ content of the SR. The Ca 2+ content was 
estimated by blocking SERCA and quantifying the in-
crease in [Ca 2+ ] c caused by calcium leakage out of the SR. 
To block SERCA, thapsigargin was used in MTSMC and 
CPA in HBSMC. The different drugs were used because 
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 Fig. 10. HBSMC were loaded with the Ca 2+ indicator Oregon 
Green, monitored with fluorescence microscopy and exposed to 
1   M ACH.  a Blocking IP 3 R using 10   M xestospongin D, the 
ACH-induced Ca 2+ transients were reduced. Using 10   M xesto-
spongin C, no effect could be observed (n = 33–57).  * p  ! 0.05 
versus controls and xestospongin C.  b But, 10   M xestospongin C 
reversed the increased ACH-induced Ca 2+ transients after incu-
bation with IL-13 or IL-4 (n = 20–57).  * p  ! 0.05 versus controls 
and interleukin/xestospongin C. Xesto = Xestospongin. 
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each of them gave a maximal response in the respective 
cells. Speculatively, the reason for this difference may be 
different SERCA subtypes, as SERCA 2 exists in the iso-
forms 2A and 2B, although the investigation of this ques-
tion was beyond the scope of this study. In cardiac smooth 
muscle cells, a decreased Ca 2+ content of the SR has been 
shown in cardiac hypertrophy  [35] and has been found to 
be responsible for defective excitation-contraction cou-
pling in heart failure  [36] . On the other hand, Asano and 
Nomura  [37] found the Ca 2+ content of the SR in arterial 
smooth muscle cells to be increased in spontaneously hy-
pertensive rats. In a previous study, we could show that 
increased bronchial reactivity in lung slices of T-bet KO 
mice correlated with increased Ca 2+ content of the SR in 
bronchial ASMC from these mice  [32] . We now confirm 
these data in MTSMC from T-bet KO mice and in inter-
leukin-treated HBSMC. We believe that in the future an 
altered regulation of the Ca 2+ content of the SR may prove 
to be involved in a number of diseases with altered mus-
cle cell function.
 In the SR, calcium is buffered by Ca 2+ chelators, which 
are high-capacity/low-affinity buffers combining the 
storage of large quantities of calcium with its rapid re-
lease. The storage proteins that are believed to be ex-
pressed in smooth muscle at the highest levels are calre-
ticulin and calsequestrin  [33] . In MTSMC from T-bet KO 
mice, we found these 2 buffers to be upregulated. Al-
though the increase in expression of calreticulin was sta-
tistically significant, it appeared low given the strong 
baseline expression of calreticulin, rendering the mean-
ing of this finding somewhat unclear. In contrast, the ex-
pression of calsequestrin was considerably higher in 
MTSMC from T-bet KO mice. In HBSMC, we found a 
statistical increase in the expression of calreticulin after 
incubation with IL-13, but not with IL-4. Given the strong 
upregulation of IP 3 R, RyR and SERCA 2, this finding ap-
pears to be of minor importance. However, this is – to our 
knowledge – the first report of an upregulation of SR Ca 2+ 
buffers in ASMC in an asthma model.
 ATP-dependent SERCA pumps force calcium out of 
the cytoplasm and into the SR. Three SERCA isoforms 
have been identified, with SERCA 2 being the isoform 
that is predominant in smooth muscle  [33] . In HBSMC, 
the expression of SERCA 2 was increased after incubation 
with IL-13 or IL-4. A higher capacity to pump calcium 
against the concentration gradient into the SR could lead 
to a higher SR Ca 2+ content. However, the question arises 
how the calcium is stored in the SR, as the 2 Ca 2+ buffers 
investigated were not upregulated accordingly. Specula-
tively, so far undescribed Ca 2+ buffers may contribute to 
the overall buffer capacity of the SR and may have been 
upregulated by the incubation with the interleukins. Al-
ternatively, the capacity to buffer calcium was sufficient 
to store the increased amount of calcium without the 
need to increase protein expression. In heart failure, the 
activity of SERCA was found to be decreased  [38] and 
these pumps are currently being investigated as a possible 
target for heart failure therapy  [39] . Thus, decreased con-
tractility of cardiac myocytes leads to heart failure, while 
increased contractility of ASMC may lead to asthma. The 
investigation of SERCA therefore seems promising in dis-
eases connected with altered muscle contractility.
 After the binding of ACH to its receptor, activation of 
phospholipase C produces IP 3 , which releases calcium 
from the SR via the IP 3 R channel. As an example for a 
pathophysiological role for IP 3 R, it has been shown to 
support proarrhythmic Ca 2+ signals in cardiac myocytes 
 [40] . We found the expression of IP 3 R to be increased af-
ter incubation of HBSMC with IL-13 or IL-4. A cytoplas-
mic Ca 2+ increase via IP 3 R triggers calcium-induced cal-
cium release from the SR via RyR  [41] . RyR dysfunction 
has been detected in heart failure and ventricular tachy-
cardia as well as in striated muscle diseases, and RyR-sta-
bilizing drugs have been demonstrated to be effective in 
the corresponding disease models  [42] . In MTSMC, only 
weak expression of RyR could be detected, with no appar-
ent difference between T-bet KO and wild-type mice. But, 
in HBSMC, incubation with IL-13 or IL-4 noticeably in-
creased the expression of RyR. The upregulation of IP 3 R 
and RyR in HBSMC obviously did not directly lead to an 
increased SR Ca 2+ content, as these receptors are SR Ca 2+ 
release channels. However, these receptors contributed to 
the release of a greater amount of calcium out of the SR, 
as seen in response to ACH. To take advantage of this 
finding, we used xestospongins to investigate if inhibi-
tion of IP 3 R could be used to reduce the elevated ACH-
induced Ca 2+ signaling in HBSMC after incubation with 
IL-13 or IL-4. Xestospongins are a family of potent in-
hibitors of IP 3 R, of which xestospongin C is believed to 
be the most potent one and xestospongin D to be less ef-
fective  [34] . Without interleukins, xestospongin D de-
creased ACH-induced Ca 2+ transients, while incubation 
with xestospongin C had no effect. But, xestospongin C 
reversed the IL-13- and IL-4-mediated increase in ACH-
induced Ca 2+ transients. The different effects of xesto-
spongin C and D may be due to different affinities to 
IP 3 R. In turn, differences in the affinities may be depen-
dent on the isoform of the receptor  [34] . So far, 3 isoforms 
of IP 3 R have been isolated and all 3 are expressed in 
smooth muscle  [33] . But, to our knowledge, the affinities 
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